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INTRODUCTION 
              Stroke is defined as the syndrome of rapid onset of cerebral 
deficit, usually focal, lasting for more than 24 hours or leading to death 
with no cause apparent other than the vascular one (1). As a result of this 
explanation transient ischemic attack (TIA), which is defined to last less 
than 24 hours, and patients with symptoms similar to stroke due to 
various causes such as subdural hemorrhage, tumors, poisoning, or 
trauma are barred (2). Stroke may lead to the long term complications 
which caters under the most common causes for mortality and the 
morbidity both international as well as national level(3) and stroke itself is 
the second commonest cause for increasing mortality worldwide (4).Hence 
stroke is considered as an significant health issue as it has its impact 
strongly  not over the individual alone but also over the social factors 
(5).The main risk factors associated with the occurrence of stroke are 
elevated blood pressure ,uncontrolled diabetes, dyslipidemia, smoking 
and alcoholism. Though new modalities of treatment have evolved, still 
the prognosis is considered to be poor due to all these risk factors 
implications over the treatment (6). 
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Based on several ways stroke can be classified as follows: (7) 
1. According to Clinical features  
1. Completed stroke. 
2. Stroke in Evolution. 
3. Transient Ischemic Effects. 
4. Reversible Ischemic Neurological Deficit. 
2. According to anatomic site 
a. Supra-tentorial which includes lobar and Capsulo-ganglionic 
b. Infra-tentorial which includes brainstem and cerebellum. 
3. According to pathophysiology: 
 I. Infarct 
           Thrombotic 
            Embolic 
     II. Hemorrhagic stroke. 
 Among the various types of stroke the two main types are ischemic 
stroke and the hemorrhagic stroke. Ischemic stroke is due to the blockage 
of blood supply to the brain due to arterial occlusion, which can cause 
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damage to brain cells. Hemorrhagic stroke is the one caused when a 
blood vessel bursts within or on the surface of the brain (8). Ischemic 
stroke accounts for about 50 % -85 % of stroke all over the world (9).  
Acute ischemic stroke 
             The greater part of strokes happen when blood vessels to the 
brain turn out to be lessened or congested with fatty deposits called 
plaque which cuts off blood flow to the brain cells. The stroke due to the 
deficiency in the blood flow reaching part of the brain is called an 
ischemic stroke (10). 
Ischemic stroke is categorized into two types namely (10) 
1. Thrombotic stroke  
2. Embolic stroke 
 
Common causes (20) 
1. Thrombosis 
a. Lacunar 
b. Large vessel thrombosis 
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2. Embolic 
a. Artery to artery embolic occlusion- at carotid bifurcation, aortic 
arch 
b. Cardio embolic –  
Atrial fibrillation 
Mural thrombu 
Myocardial infarction 2-3% incidence 
Valvular lesions like [MS, bacterial endocarditis, mechanical 
 valve] 
c. Paradoxical embolus like ASD, patent foramen ovale 
d. Stimulant drugs – cocaine, Amphetamine 
Uncommon causes 
1. Hypercoagulable states-  
                                APLA, Protein-C deficiency, Protein S deficiency, 
                                Sickle cell anemia, Homocystinemia. 
2. Venous sins thrombosis 
3. Vasculitis- PAN, Wegeners, Takayasu arteritis. 
4. Fibro muscular dysplasia 
5. Cardiogenic- Marantic endocarditis, atrial myxoma. 
Genes involved in stroke  
a.  The presence of Apo İ 4 allele along with elevated 
triglycerides, hypertension, and age could predict the 
development of stroke. 
b. MTHFR C677T mutations (MTHFR gene is involved with 
metabolism) was found to be strongly associated with 
arterial stroke, especially in young.(11) 
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c. F2 and F5 genes increase the risk of thrombosis. 
d. Cerebral arteriopathy, autosomal dominant, with subcortical 
infarcts and leucoencephalopathy (CADASIL), is caused by 
mutations in the NOTCH3 gene.(12) 
e. 2 single nucleotide polymorphisms on 2q23.3 is involved in 
early onset ischemic stroke. 
f. HDAC9, PITX2, and ZFHX3 genes involved on large vessel 
stroke.(13) 
g. Mutations in the CST3 gene are inherited in an autosomal 
dominant manner results in Amyloid angiopathies are also 
known to increase risk for stroke and dementia.(14) 
Mutations in the following genes also are known to increase the risk of 
stroke (15) 
1. NOS3: A nitric oxide synthetase gene; involved in vascular 
relaxation  
2. ALOX5AP: Involved in the metabolism of arachidonic acid  
3. PRKCH: Involved in major signal transduction systems  
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Thrombotic stroke 
           Thrombogenic factors may cause injury to endothelial cells; results 
in platelet activation by the sub endothelium, activation of the clotting 
cascade, inhibition of fibrinolysis, and blood stasis.  
          Thrombotic strokes are generally thought to originate on ruptured 
atherosclerotic plaques. Arterial stenosis can cause turbulent blood flow, 
which can promote thrombus formation; atherosclerosis (i.e., ulcerated 
plaques); and platelet adherence. All cause the formation of blood clots 
that either embolize or occlude the artery. Intracranial atherosclerosis 
may be the cause of thrombotic stroke in patients with widespread 
atherosclerosis (16) 
Embolic stroke: 
20%  of ischemic stroke. Stroke is due to embolism of thrombotic 
material formed on arterial or ventricular wall or left heart valves. Emboli 
may arise from the heart, the extra cranial arteries, including the aortic 
arch or, rarely paradoxical emboli arising from right sided circulation 
with subsequent passage through a patent foramen ovale (17) 
 Sources of cardiogenic emboli include the following: 
x Valvular thrombi (eg, in mitral stenosis or endocarditis or from use 
of a prosthetic valve) 
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x Mural thrombi (eg, in myocardial infarction, atrial fibrillation, 
dilated cardiomyopathy, or severe congestive heart failure) 
x Atrial myxoma. 
 Emboli from heart mostly lodge in intracranial internal carotid 
artery, MCA, PCA, infrequently in ACA. Large emboli of size 3-4 mm 
can occlude the stem of MCA and cause large infarcts. Location and size 
of infarct depends on collateral circulation. Emboli originating from the 
aortic arch and diffuse thrombotic or inflammatory processes that can 
lead to multiple small-vessel occlusions or bilateral infarcts (18, 19) 
 Non rheumatic atrial fibrillation is the most common cause of 
cerebral embolism. Embolic strokes tend to have a sudden onset, and 
neuroimaging may demonstrate previous infarcts in several vascular 
territories or may show calcific emboli. 
 
 
 
 
Figure 1: Ischemic stroke 
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Figure2: Transient ischemic stroke 
Mechanism of stroke 
Large-Vessel Atherothrombosis (60) 
 It affects both extra cranial and intracranial arteries due to the lipid-
laden atherosclerotic plaques deposition on the inner wall of a large 
vessel. This plaques formation is more common at the bifurcations of the 
common carotid arteries, the origins of the vertebral arteries, and the 
course of the middle cerebral artery prior to its trifurcation. Risk factors 
for deposition are high blood pressure, diabetes mellitus, and 
dyslipidaemia. There will be gradual reductions in CBF over a long 
period without any infarcts until stenosis is reached at a critical level. 
Depending on the vessels involved and the presence or absence of 
anastomoses, this mechanism typically results in a single large territorial 
stroke. 
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 In the case of so-called atheroembolism, a thrombus that has 
formed on the wall of a particular vessel may break apart and lodge along 
the branches of small arteries, resulting in multiple smaller infarcts within 
the expected branches of the parent vessel. 
Small-Vessel Disease (61) 
Occlusive disease involving the microcirculation of the brain 
results in small vessel ischemic disease.  
Lacunar infarct causes includes (20)  
Microatheroma  
Lipohyalinosis  
Fibrinoid necrosis as a result of hypertension or Vasculitis. 
   Common locations for small-vessel disease include deep areas of the 
hemispheric white matter such as 
1. The corona radiata 
2. The internal capsule, adjacent to the proximal middle cerebral 
artery which is supplied  by its penetrating branches; 
3. The pons in the mid-brainstem, supplied by penetrators arising 
from the basilar artery;  
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4. The thalamus, reliant primarily on branches of the posterior 
cerebral arteries.  
Infarctions of these typical regions are classically small (<1.5 cm). 
Depending on the location within the brain usually produce one of the 
classic lacunar syndromes depends upon site of lacunar infarct. 
¾ Pure motor  symptoms, usually face + arm or arm + leg, 
comprising 33–50 % of all small-vessel strokes ; 
¾ Pure sensory;  
¾ Mixed sensorimotor  
¾ Ataxic hemiparesis, which features weakness of one side 
with disproportionate clumsiness (ataxia) of the same side; 
and  
¾ Clumsy hand- dysarthria, clumsiness of either hand, out of 
proportion to any weakness of the limb, combined with 
slurred speech. 
 Other lacunar syndromes referable to the posterior circulation have been 
recognized, such as hemiballism, hemichorea, and isolated dysarthria, but 
they are less commonly seen as results of acute stroke. 
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Watershed infarcts 
Vascular watershed infarctions occur at the most distal areas 
between arterial territories occurs secondary to embolic phenomenon or 
to severe hypoperfusion, as occurs, for example, in carotid occlusion or 
prolonged hypotension (21,22,23) 
Hemorrhagic stroke (20) 
 Hemorrhagic stroke occurs when a blood vessel bursts inside the 
brain. The brain is very sensitive to bleeding and Bleeding irritates the 
brain tissue, causing swelling. Bleeding collects into a mass called a 
hematoma. Bleeding also increases pressure on the brain and presses it 
against the skull, 
There are two possible causes of a ruptured blood vessel in the brain. 
 The most common cause is an aneurysm. 
A rarer cause of an ICH is an arteriovenous malformation (AVM).’ 
 An aneurysm occurs when a section of a blood vessel becomes enlarged 
from chronic and dangerously high blood pressure or when a blood vessel 
wall is weak, leading to thinning of the vessel wall, and ultimately to a 
rupture. 
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Figure 3: Intra cerebral Haemorrhage 
RISK FACTORS OF STROKE: 
Non modifiable risk factors (24) 
a. Age 
b. Race  (Africo-Caribbean population >Asian  population> 
European population 
c. Sex 
d. Ethnicity 
e. History of migraine headaches 
f. Fibro muscular dysplasia 
g. Heredity: Family history of stroke or transient ischemic attacks 
(TIAs) 
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Modifiable risk factors (25) 
x Hypertension (the most important) 
x Diabetes mellitus 
x Cardiac disease: Atrial fibrillation, valvular disease, heart failure, 
mitral stenosis, structural anomalies allowing right-to-left shunting 
(eg, patent foramen ovale), and atrial and ventricular enlargement 
x Hypercholesterolemia 
x Transient ischemic attacks (TIA) 
x Carotid stenosis 
x Hyperhomocystinemia 
x Lifestyle issues: Excessive alcohol intake, tobacco use, illicit drug 
use, physical inactivity(26) 
x Obesity 
x Oral contraceptive use/postmenopausal hormone use 
x Sickle cell disease 
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Pathogenesis: 
Acute ischemic stroke occurs due to vascular occlusion secondary to 
thromboembolic disease. Ischemia causes cell hypoxia and depletion of 
cellular ATP, due to this loss of energy to maintain ionic gradients is lost 
across the cell membrane leading to cellular depolarization (16). 
Ischemic core and penumbra 
An acute vascular occlusion produces heterogeneous regions of 
ischemia in theaffected vascular territory.  
Affected regions with cerebral blood flow of lower than 10 ml/100g of 
tissue/min are referred to as the core.  
   Affected regions with cerebral blood flow of lower than 25 ml/100 g of 
tissue/min are referred to as ischemic penumbra (27). 
Ischemic cascade  
      Sodium - potassium pump fails due to depletion of ATP resulting in 
intracellular increase in sodium, thereby increasing intracellular water 
content. This cellular swelling produces as cytotoxic edema and occurs 
very early in cerebral ischemia. Also the Cerebral ischemia impairs the 
normal sodium-calcium exchange protein resulting in calcium influx , 
leading to release of neurotransmitters, such as glutamate, activating N -
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methyl-D-aspartate (NMDA) and other excitatory receptors present in 
neurons . Cell membrane and other neuronal structures get destructed (28) . 
Haemorrhagic transformation of ischemic stroke 
5% of uncomplicated ischemic strokes goes for hemorrhagic 
transformation in the absence of fibrinolytic therapy (29). 
Mechanism: 
   1] Reperfusion of ischemically injured tissue, either from 
recanalisation of an occluded vessel or from collateral blood supply to 
the ischemic territory  
  2] Disruption of the blood-brain barrier and extravasation of red 
blood cells from the weakened capillary bed, producing petechial 
haemorrhage or more frank intraparenchymal hematoma (5). 
Post stroke cerebral edema and seizures 
                Although clinically significant cerebral edema can occur 
after anterior circulation ischemic stroke, it is thought to be somewhat 
rare (10-20%).  Edema and herniation are the most common causes of 
early death in patients with hemispheric stroke (5). 
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  Seizures occur in 2-23% of patients within the first days after 
ischemic stroke. A fraction of patients who have experienced stroke 
develop chronic seizure disorders. 
SIGNS AND SYMPTOMS (9, 30, 20) 
Consider stroke in any patient presenting with acute neurologic deficit 
or any alteration in level of consciousness. Common stroke signs and 
symptoms include the following: 
x Abrupt onset of hemiparesis, monoparesis, or (rarely) quadriparesis 
x Hemisensory deficits 
x Monocular or binocular visual loss 
x Visual field deficits 
x Diplopia 
x Dysarthria 
x Facial droop 
x Ataxia 
x Vertigo (rarely in isolation) 
x Nystagmus 
x Aphasia 
x Sudden decrease in level of consciousness 
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STROKE SYNDROMES 
Middle cerebral artery stroke 
The MCA supplies the upper extremity motor strip. Consequently, 
arm and face weakness is more than that of the lower limb. 
Middle cerebral artery (MCA) occlusions commonly produce the 
following: 
x Receptive or expressive aphasia, if the lesion occurs in the dominant 
hemisphere 
x Gaze preference toward the side of the lesion 
x Contralateral hemiparesis 
x Contralateral hypoesthesia 
x Ipsilateral hemianopia 
x Agnosia 
Anterior cerebral artery stroke 
It primarily affects frontal lobe function. Findings in ACA stroke may 
include the following: 
x Altered mental status 
x Impaired judgment 
x Disinhibition and speech perseveration 
x Primitive reflexes (eg, grasping, sucking reflexes) 
18 
 
x Contralateral weakness (greater in legs than arms) 
x Contralateral cortical sensory deficits 
x Gait apraxia 
x Urinary incontinence 
Posterior cerebral artery stroke 
It affects vision and thought. Manifestations include the following: 
x Impaired memory 
x Altered mental status 
x Contralateral homonymous hemianopia 
x Cortical blindness 
x Visual agnosia 
Vertebro basilar artery occlusion 
It may cause a wide variety of cranial nerve, cerebellar, and 
brainstem deficits. Wallenberg's syndrome occurs due to the Posterior 
inferior cerebellar artery occlusion (PICA), vertebral, or superior, middle 
or inferior lateral medullary arteries. This syndrome is characterized by 
contralateral impaired pain and temperature sensation (spinothalamic 
tract involvement) and the same side numbness over half of the face, 
ataxia, Horner’s syndrome, dysphagia, vertigo, Hiccups and loss of taste 
sensation. The main feature of posterior circulation stroke is the presence 
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of crossed findings: Ipsilateral cranial nerve deficits and contralateral 
motor deficits. 
LACUNAR STROKE TYPES 
 
 
Neurologic examination: 
Accurate  neurologic examination on patients with suspected stroke 
syndromes.  
The goals of the neurologic examination include the following: 
¾ Confirming the presence of a stroke syndrome 
¾ Distinguishing stroke from stroke mimics 
Clinical features Structure involved 
Pure motor hemi paresis Infarct in the basis pontis, 
posterior limb of Internal capsule 
Pure sensory stroke Ventral thalamus infarct   
 
Ataxic  hemi paresis 
 
Pons -Ventral portion  infarct   
 
Dysarthria and clumsy hand 
syndrome   
 
Genu of internal capsule infarct 
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¾ Establishing a neurologic baseline (including documenting an NIH 
Stroke Scale)  
¾ Establishing stroke severity to assist in prognosis and therapeutic 
selection (based on potential disability due to current neurologic 
deficits) 
Essential components of the neurologic examination include the 
following evaluations: 
 Cranial nerves 
 Motor function 
 Sensory function 
 Cerebellar function 
 Gait 
 Language (expressive and receptive capabilities) 
 Mental status and level of consciousness 
Examining the skull and spine and signs of meningismus should be 
sought. 
 Stroke mimics commonly confound the clinical diagnosis of stroke. . 
The most frequent stroke mimics include the following: 
1. Seizure (17%) 
2. Systemic infection (17%) 
3. Brain tumour (15%) 
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4. Toxic-metabolic disorders, such as hyponatremia and 
hypoglycaemia (13%)(58) 
5. Positional vertigo (6%) 
6. Conversion disorder 
  Ischemic stroke is distinguished from hemorrhagic stroke by 
neuroimaging; the following clinical findings increase the probability of 
hemorrhagic stroke: 
9 Coma  
9 Neck stiffness  
9 Seizures accompanying the neurologic deficit  
9 Diastolic blood pressure >110 mm Hg  
9 Vomiting  
9 Headache 
The probability of haemorrhages decreased if there is cervical bruit and 
prior transient ischemic attack. 
IMAGING STUDIES   
x CT angiography and CT perfusion scanning 
x Magnetic resonance imaging (MRI) 
x Carotid duplex scanning 
x Digital subtraction angiography. 
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CT scans (24) 
CT scan helps in the clear differentiation between haemorrhages and 
infarct and it also helps to detect abscess, tumour mass lesions, and extra 
parenchymal haemorrhages. 
                                      
          Figure 4: Infarct                                       Figure 5: Haemorrhage 
CT Angiography 
Carotid disease and intracranial vascular occlusions are readily 
identified by this method. 
 Merits:   
1. Helps the treating physician to decide the line of management by 
distinguishing infarct and hemorrhage.   
2. Highly sensitive in detecting Subarachnoid Hemorrhage.  
3. Wide availability and its early results to decide treatment. 
4. Cost effective than MRI.  
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Demerits:   
1. CT not usually detects the infarct within first 24 to 48 hours.   
2. Small infarct on the cortical surface will be missed. 
3. Usually CT scans will not detect the posterior fossa lesions due to 
artifact (bone).   
MRI Scan (20) 
     1. Posterior fossa infarction and cortical infarction can be easily 
identified in MRI 
     2. Early brain infarction can be easily determined by DW Images. 
    3. Stenosis of intracranial vessels and extra cranial internal carotid 
arteries stenosis were detected by MR Angiogram. 
Merits: 
     In TIA patient, MRI more likely to detect new infarction, which is a 
strong predictor of subsequent stroke. 
Demerits: 
1.  More expensive and time consuming. 
2. Not readily available everywhere. 
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MANAGEMENT 
Primary stroke prevention refers to the treatment of individuals 
with no previous history of stroke.  
 Platelet antiaggregants 
x Statins 
x Exercise 
x Lifestyle interventions (eg, smoking cessation, alcohol moderation) 
Secondary prevention refers to the treatment of individuals who have 
already had a stroke.  
x Platelet antiaggregants 
x Antihypertensive 
x Statins 
x Lifestyle interventions 
Emergency Management  
The goal for the emergent management of stroke is to complete the 
following within 60 minutes or less of patient arrival (24) : 
x Assess airway, breathing, and circulation (ABCs) and stabilize the 
patient as necessary 
x Complete the initial evaluation and assessment, including imaging 
and laboratory studies 
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x Initiate reperfusion therapy, if appropriate 
Critical treatment decisions focus on the following: 
x  airway management 
x Optimal blood pressure control 
x Identifying potential reperfusion therapies (eg, intravenous 
fibrinolysis with rt-PA (Alteplase) or intra-arterial approaches. 
Treatment of comorbid conditions may include the following: 
x Reduce fever 
x Correct hypotension/significant hypertension 
x Correct hypoxia 
x Correct hypoglycaemia 
ISCHEMIC STROKE THERAPY 
Ischemic stroke therapies include the following: 
x Antithrombotic treatment   
x Fibrinolytic therapy (31)  
x Mechanical thrombectomy 
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ANTITHROMBOTIC TREATMENT 
Platelet inhibition:  
1. Aspirin (ASA): 
Aspirin blocks prostaglandin synthetase action, which in turn 
inhibits prostaglandin synthesis and prevents the formation of 
platelet-aggregating thromboxane A2. It also reduces fever by 
acting on the hypothalamic heat-regulating center (32) 
          For ischemic Stroke & Transient Ischemic Attack:  
50-325 /day Per oral within 48 hours of stroke or TIA, then 75-100 
mg/day Per Oral 
 
2. Dipyridamole and Aspirin: 
The combination of extended-release Dipyridamole and Aspirin 
reduces the relative risk of stroke, death, and myocardial infarction 
(MI). It is used for the secondary prevention of ischemic stroke and 
TIA. 
ANTICOAGULATION (33) 
Anticoagulation should be advised for all patients with atrial 
fibrillation due to nonvalvular heart disease and cardiac disease. Cerebral 
embolism can be prevented by maintaining INR between 2-3. 
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 Indications of anticoagulation for 3 months include: 
1. Left ventricular dysfunction 
2. Atrial fibrillation 
3. Anterior Q –wave infarction 
4. Mural thrombus 
5. Congestive cardiac failure 
STATINS (34)  
These drugs were effective in reducing the cholesterol levels 
particularly Low density lipoproteins and very effective in reducing the 
incidence of Coronary artery disease and cerebrovascular accidents.   
These statins has the following properties:   
1. Normalizes the vascular endothelium   
2. Reducing inflammation   
3. Stabilizes the plaques mainly the central lipid core mass. 
FIBRINOLYTIC THERAPY (35) 
Alteplase(rt-PA), the only fibrinolytic agent that has been shown to 
benefit selected patients with acute ischemic stroke. In May 2009 the 
AHA/ASA revised the guidelines for the administration of rt-PA after 
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acute stroke, expanding the window of treatment from 3 hours to 4.5 
hours to provide more patients with an opportunity to benefit from this 
therapy. 
Table 1: Indication and Contraindication for Fibrinolytic therapy 
Indication for rt-PA  
1. CT showing haemorrhage or 
oedema of >1/3 of MCA 
territory. 
2.Symptom onset to drug 
administration time <4.5 hours 
3. Age>18 years.  
4.Consent by patient or 
relatives 
 
 
Contraindication for rt-PA 
1.Platelet <1 lakh; Hct<25%; 
2.Blood glucose <50 or >400 
3.Sustained BP>185/110; 
4.Use of heparin within 48 hours 
5. Recent head injury within 3 
months or any GI surgery within 2 
weeks. 
6.Recent MI 
7. Rapidly improving symptoms. 
 
Mechanical Thrombectomy or endovascular revascularisation: (36) 
In large vessel occlusions like MCA, intracranial ICA, basilar 
artery, the clot fails to open with rt-PA alone. So intravascular route of 
thrombolytics used. It is an alternative for patients in whom fibrinolysis is 
ineffective or contraindicated. In 2015, The American Heart 
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Association/American Stroke Association issued updated guidelines for 
the emergency treatment of patients with acute ischemic stroke, 
recommending endovascular treatment using the newer generation stent 
retrievers (37), Currently,  4  devices  are  approved  by  the  FDA  for  the  
endovascular treatment of acute ischemic stroke. 
STEM CELL THERAPY: 
 Chronic ischemic stroke has potential benefit with stem cell 
therapy by not only through formation of neurons at infarct zone but also 
as cellular mediators of many of the biological mechanisms. 
        Intravenously administered stem cell will help in up regulation of 
growth factors within the body and brain making the host environment 
conducive for behavioural recovery in the form of ‘learning’ (38). They 
observed that autologous bone marrow-derived mononuclear cells are 
safe in chronic ischemic stroke. 
NEUROPROTECTION  
Neuroprotective drugs blocks the neuro- excitatory amino acid 
pathway and it promotes the tolerance of brain to ischemic effects.  
1. Calcium Channel Antagonists (e.g., Flunarizine, and 
Darodipine)(39) 
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2. Non-competitive N-methyl–D-aspartate receptor 
antagonists(e.g., Dextromethorphan, Eliprodil)  
3. Phosphatidyl choline synthesis (e.g.Citicholine)  
Citi choline - is an exogenous form of cytidine-5'-
diphosphocholine (CDP-choline) used in membrane 
biosynthesis. Citi choline decreasing free radical formation by 
reducing ischemic injury and stabilizing the membranes.(40) 
Treating Associated Co-morbidities: (20) 
1.  Prolong bed ridden state- DVT prophylaxis – pneumatic 
compression stockings, LMW Heparin .Treating infections like 
UTI, pneumonia with antibiotics. 
2. Blood pressure is lowered if associated malignant hypertension, 
or if BP>185/110, if thrombolytic therapy is anticipated.  
Beta blocker (Esmolol) is used. 
3.  Fever is detrimental and it is treated with antipyretics, 
4.  If massive infarct causing cerebral edema and brain herniation: 
Water restriction and IV Mannitol is used. 
5.  Blood glucose should be maintained<180mg% using insulin 
infusion if necessary. 
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STROKE REHABILITATION (24) 
     a) Speech therapy   
b) Occupational therapy   
c) Physical therapy   
d) Pharmacological therapy 
COMPLICATIONS OF STROKE (24) 
1. Aspiration Pneumonia  
2. Urinary tract infection   
3. Bed sores  
4. Pulmonary embolism with Deep vein thrombosis  
5. Contractures  
6. Dehydration  
7. Hypoxemia   
8. Hyperglycaemia 
9. Frozen Shoulder and subluxation   
10. Constipation   
11. Hyponatremia and seizures. 
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Prognosis 
In the Framingham and Rochester stroke studies, the overall 
mortality rate at 30 days after stroke was 28%, the mortality rate at 30 
days after ischemic stroke was 19%, and the 1-year survival rate for 
patients with ischemic stroke was 77%. In ischemic stroke, prognosis 
varies in individual patients, depending on patient’s premorbid condition, 
age, and post stroke complications (32) 
Stroke survivors from the Framingham Heart Study- 
 31% needed help caring for themselves,  
20% needed help when walking, and  
71% had impaired vocational capacity in long-term follow-up. 
Role of Calcium in stroke 
 Calcium is the most prevalent cation in the human body. 
Approximately 1-1.3 kg of calcium can be found in a healthy adult, 99% 
of which is in the form of hydroxyapatite in the skeleton; the remaining 
1% in the extracellular fluid (ECF).Serum (plasma) calcium exists in 3 
distinct forms. 
The serum calcium is divided into three fractions:  
1. 50% of calcium ions in the active form,  
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2. 40% bound to serum proteins, principally albumin and  
3. 10% bound to anions such as bicarbonate and citrate. 
Calcium (Ca2+) ions play a physiological role in the multiple patho 
mechanisms of cerebral ischemia. (40) 
 Normal CBF is between 45 and 60 ml blood/100 g/min. It is well 
documented that time-dependent neuronal events are triggered in 
response to reduced CBF (41), there is an interruption in the oxygen 
dependent generation of high-energy compounds, when the CBF falls 
below 10 ml/min/100 g, this leads to a disturbance in cellular calcium 
homeostasis. Cerebral ischemia results in intracellular accumulation of 
calcium which activates cytotoxic enzyme leading to cell death. (42). A 
rapid and massive influx of calcium into the cell results. 
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The reduction of blood flow supply to the brain during ischemic 
stroke results in oxygen and glucose deprivation and thus a reduction in 
energy available to maintain the ionic gradients. This results in excessive 
neuronal depolarization and deregulated glutamate release.  If blood flow 
is reduced for a long period, Glutamate is released at high concentrations 
in the penumbral cortex (43) and the amount of glutamate released 
correlates with early neurological deterioration in patients with acute 
ischemic stroke (44).  
 After a stroke, as a consequence of excessive extracellular 
glutamates, NMDARs are excessively activated resulting in increased 
Ca2+ influx (45). In the excitotoxic cascade, Calcium plays a critical role, 
because either removing Ca2+ from extracellular medium or preventing 
Ca2+ from entering mitochondria by uncouplers protects neurons against 
excitotoxic injury. 
N-methyl-d-aspartate (NMDA) glutamate receptors are believed to 
be the key mediators of death during excitotoxic injury (46).Mitochondrial 
dysfunction as a consequence of prolonged accumulation of Ca2+ is 
considered a major source of free radicals that are generated after 
ischemia-reperfusion (47,48). Excitotoxicity causes a sudden increase in 
cytoplasmic Ca2+ concentrations in neurons after ischemia, which 
induces activation of several signalling pathways, leading to apoptotic or 
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necrotic neuronal death. Activation of calpains, caspases, other proteases, 
kinases and endonucleases, cause mitochondrial disturbance, 
overproduction of free radicals and DNA fragmentation, that 
synergistically leads to neuronal death. 
 Oxidative stress induced by excitotoxicity is considered the main 
event leading to brain damage after cerebral ischemia (49),  The  most  
important free radicals induced by excitotoxicity are reactive oxygen 
species and reactive nitrogen species. 
Low serum calcium found after acute ischemic stroke is 
significantly associated with greater severity of stroke as assessed by the 
National Institute of Health Stroke Score (NIHSS) than those with high 
calcium levels. Since about half of calcium in the blood is bound 
to albumin, an abnormally high or low level of albumin may affect the 
interpretation of calcium results and "free" or "ionized calcium" must be 
measured. 
The first step in the evaluation of a patient with hypocalcaemia is 
to verify with repeat measurement (total serum calcium corrected for 
albumin or ionized calcium) that there is a true decrease in the serum 
calcium concentration. 
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Table 2: Conditions with decreased and increased calcium levels 
 
Calcium in serum is bound to proteins, principally albumin. As a 
result, the total serum calcium concentration in patients with low or high 
serum albumin levels may not accurately reflect the physiologically 
important ionized (or free) calcium concentration. Each 1 g/dL reduction 
in the serum albumin concentration will lower the total calcium 
concentration by approximately 0.8 mg/dL (0.2 mmol/L) without 
Conditions with increased calcium 
level 
Conditions with decreased calcium 
levels 
Hyperparathyroidism 
Malignancies like squamous cell 
carcinoma of lung, renal cell 
carcinoma, 
Vitamin D excess 
Multiple myeloma 
Paget disease of bone 
Sarcoidosis 
Drugs like some antacids, long term 
thiazides, lithium. 
 
 
 
Hypoparathyroidism 
Vitamin D deficiency 
Chronic kidney disease 
Hyperphosphatemia 
Massive transfusion 
Hypoalbuminemia 
Chronic liver disease., biliary 
obstructive disease 
Severe dietary calcium deficiency. 
Severe sepsis 
Tumor lysis syndrome. 
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affecting the ionized calcium concentration and, therefore, without 
producing any symptoms or signs of hypocalcaemia.   
  Hypoalbuminemia is the most common cause of hypocalcaemia. 
Causes include 
1. Cirrhosis,  
2. Nephrosis, 
3. Malnutrition, 
4. Burns,  
5. Chronic illness, 
6. Sepsis. 
  In patients who are critically ill, low calcium levels can be simply 
due to Hypoalbuminemia. 
The reference range for albumin testing is as follows: (5) 
x The normal range is 3.5 to 5.5 g/dL or 35-55 g/litre. This range may 
vary slightly in different laboratories. 
x Albumin composes 50%-60% of blood plasma proteins.. 
Calcium is maintained within a fairly narrow range from 8.5 to 10.5 
mg/dl (4.3 to 5.3 m Eq /L or 2.2 to 2.7 mmol /L). Normal values and 
reference ranges may vary among laboratories as much as 0.5 mg/dl. 
Concentrations of total calcium in normal serum generally range between 
8.5 and 10.5 mg/dL (2.12 to 2.62 mmol/L) and levels below this are 
considered to be consistent with hypocalcaemia. 
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The normal range of ionized calcium is 4.65 to 5.25 mg/dL (1.16 to 
1.31 mmol/L). 
Formula  
Corrected Ca = [0.8 x (normal albumin - patient's albumin)]  +   
                                                                serum Ca  level. 
Accordingly normal corrected calcium value is taken as 8.6 to 10.2.         
NATIONAL INSTITUTE OF HEALTH STROKE SCALE (NIHSS) 
For assessing the impairment due to stroke National Institute of 
Health Stroke scale was formed. The NIHSS was designed to be a 
uniform assessment of stroke patients by large multi-centre clinical trials 
(50). This scale has been accepted widely due to eminent levels of score 
consistency. Consistency of NIHSS scores has been established in inter-
examiner and in test-retest scenarios (51). The NIHSS is repeated at 
customary intervals or following noteworthy changes in patient 
appearance. This  scores can also  be utilized to scrutinize the efficiency 
of  the treatment  method and enumerate the  patient’s enhancement or 
turn down (52).The NIHSS can also be used for prospective observational 
study, to envisage 3 month outcomes of patients with under nutrition 
during hospital stays directly after a stroke (53). 
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National Institute of Health Stroke scale consists of eleven 
components, each score ranging from 0 - 4 based on the response. A 
score 0 indicates normal function, whereas a elevated score indicates 
impairment. Overall score vary from 0-42 with high values represent 
increased severity of infarcts. 
The four vital areas to be taken into consideration are as follows: 
1. Cranial Nerve/ Visual disturbances 
2. Level of Consciousness 
3. Motor weakness 
4. Language/ Neglect  
  This clinical parameter can also be used to assess and the scores can be 
computed for assessing the severity of stroke. 
Advantages of National Institute of Health Stroke Scale  (5). 
a. To assess the cerebro - vascular accidents. 
b. To determine the stoke prognosis. 
c. To establish functional disability 
d. Speedy technique of assessing the study subjects, that hardly 
needs the duration of 10 minutes. 
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NATIONAL INSTITUTE OF HEALTH STROKE SCALE (NIHSS) 
Table 3: NIHSS 
S.NO TESTED 
ITEM 
TITLE RESPONSE AND SCORE  
1 1A Level of 
consciousness 
0-Alert 
1-Ready to fall asleep, lack of 
attention, respond to painful 
stimuli. 
2-Nott alert / oriented to time, 
place, remains in a state of 
confusion or delirium. 
3-comatose and not 
responding to painful stimuli. 
2 1B Orientation 
questions 
0-Answers correctly to 2 
simple questions. 
1-Patient will answer 1 
question correctly. 
2-patient will not answer to 
any question correctly. 
3 1C Response to 
commands 
0-Patient will do both work 
and tasks perfectly. 
1-Patient will do one task 
perfectly. 
2-Patient will not do both 
tasks. 
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4 2 Gaze 0-Normal horizontal 
movements 
1-Partial gaze palsy 
2-Complete ophthalmoplegia 
5 3 Field of vision 0-Normal visual field 
1-Partial Hemianopia 
2-Complete Hemianopia 
3-Bilateral Hemianopia 
6 4 Facial movements 0-Normal 
1-Subtle facial palsy 
2-Incomplete facial weakness 
3-Unilateral complete facial 
palsy  
7 5 Motor Functions 
(Arm) 
a) Left 
b) Right 
0-No fall of forearm and hand 
when stretched and kept in 
supination for 10sec 
1-Fall of forearm and hand 
but no hit in the bed 
2-Fall of forearm and hand 
and hits the bed  
3-No movement against 
gravity 
4-Total paralysis 
8 6 Motor Functions 
(leg) 
a) Left 
b) Right 
 
0 – No fall of leg for 5sec 
1 – Fall of leg occurs but it 
doesn’t hit the bed. 
2 – Fall of leg occurs and hits 
the bed. 
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3 – No movement against 
gravity 
4 – Total paralysis 
9 7 Limb Inco-
ordination  
 
0 – Normal 
1 – Inco-ordination of only 
one limb 
2 – Inco-ordination of two 
limbs 
10 8 Sensory 
 
 
 
0 – Patient will not have any 
sensory loss 
1 – Here sensory loss is mild 
2 – Here patient will have 
severe sensory 
loss 
11 9 Language 0 – Patient can communicate 
and 
comprehend the language 
properly 
12 10 Articulation 0 – Normal 
1 – Articulation defect is mild 
2 – Articulation defect is 
severe 
13 11 Extinction or 
inattention 
(Neglect) 
 
0 – Normal 
1 – One modality of sensation 
is loss 
2 – Severe loss of sensation 
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Scores: 
0 – No stroke 
1-4 – Minor stroke 
5-15 – Moderate stroke 
15-41 – Severe stroke 
NIHSS- A Good Predictor of Progress 
       NIHSS serves as the best prognostic indicator. A baseline NIHSS 
score larger than 16 indicates a sturdy probability of death of the patient, 
while a baseline NIHSS score lesser than 6 indicates a sturdy probability 
of patients recovery. On standard, an increase of 1 point in a patient’s 
NIHSS score reduces the probability of a brilliant result by 17% (32). 
Modified Rankin Scale (MRS) 
          The modified Rankin Scale (MRS) is a commonly used scale for 
measuring the degree of disability or dependence in the daily activities of 
people who have suffered a stroke or other causes of neurological 
disability. It has become the most widely used clinical outcome 
measure for stroke clinical trials. (54)             
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TABLE 4: MRS 
S.No. Score Observations 
1 0 Patient should not have any symptoms at all 
2 1 Patient should not have any significant disability in spite 
of presence of symptoms and can able to perform routine 
daily normal activities 
3 2 Patient will have slight disability and the person cannot 
perform all routine activities but manages to do his 
personal work without help 
4 3 Patient is having moderate disability and needs some help, 
but able 
to walk without assistance. 
5 4 Patient will have moderately severe disability and cannot 
walk without help and unable to do his personal affairs 
without assistance 
6 5 Here patient is having severe disability and the affected 
individual is bedridden, urinary incontinence will be 
present and needs continuous nursing care and attention 
7 6 Dead 
 
Total score of Modified Rankin Scale (MRS): 0-6. 
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Epidemiology 
       According to the World Health Organization (WHO), 15 million 
people suffer from stroke worldwide every single year. Of these, 5 
million die, and another 5 million are left eternally disabled (55). 
        Stroke is the fifth leading cause of death in the United States and the 
leading cause of disability. Each year, approximately 795,000 people in 
the United States experience new (610,000 people) or recurrent (185,000 
people) stroke (56).  Epidemiologic studies indicate that 82-92% of strokes 
in the United States are ischemic (57). 
       Stroke is the second leading cause of death and fourth leading cause 
of disability worldwide. It is also the leading cause of functional 
impairment. 20% of survivor of stroke requires institutional care after 3 
months and 15 to 30% are permanently disabled (58). 
        Globally 400-800 strokes per 1 million populations occur among 
which 5.7 million deaths occur. 15 million new acute strokes occur every 
year. It was estimated that 28.5 million DALYs were lost due to stroke 
worldwide (5). 
Burden of stroke in India: 
        Stroke is the emerging disease in the India. 12% of all strokes occur 
in less than 40 years of age (59).Average age of stroke in developing 
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countries is 15 years younger than that of developed nations.55.6 stroke 
cases occur per 1 million populations, among which 0.63 million deaths 
occur annually. The incidence of ischemic year stroke was 3.4 per 1000 
per year, and the incidence of hemorrhagic stroke was 0.8 per 1000 per 
year. 1.44 to 1.64 million of acute stroke cases occurs every year. It was 
estimated that 6,398,000 DALYs were lost due to stroke. The case fatality 
rate is 18% to 41%. In India the case fatality rate is high compared to 
other western nations due to inadequate medical care and severity of 
lesion. Stroke prevalence among the rural India was found to be 1.1% and 
urban India was 1.9%.Stroke represents 1.2% of total death in India. 
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REVIEW OF LITERATURE 
Muhammad Ishfaq, FahimUllah, et,.al conducted a study titled 
“Correlation of serum calcium with severity of acute ischemic stroke”, a 
cross-sectional study .In this study Serum calcium of all patients was 
measured and adjusted for serum albumin level. The mean serum calcium 
-was 8.82±0.69 mg/dl (range: 6.84-10.48 mg/dl). The calcium level was 
underneath 8.7 mg/dl in47 (34.06%) patients, 8.71-9.00 mg/dl in 
32(23.19%), 9.01-9.30 mg/dl in 31(22.46%) and above 9.30 mg/dl in 28 
(20.3%) patients. The mean NIHSS of the relevant groups was 
20.19±7.865, 14.81±7.324, 19.81±6.199 and 14.82±7.727. Bivariate 
correlation was calculated between continuous data of serum calcium and 
NIHSS. The overall Pearson's correlation coefficient was r= -0.237 
(p=0.005). The value was r= -0.256 (p=0.37) among men and r= -0.193 
among   women (p=0.10).  From the inferences obtained author 
concluded the study stating that Lower serum calcium levels may be 
associated with more severe clinical findings at the onset of stroke. Serum 
calcium levels may reproduce the brutality of ischemic injury hence more 
studies were in need to clarify and assess the role of calcium as the 
prognostic factor and the strategy for preventing stroke. 
           Meghna Borah, SriparnaDhar, Dipankar Mall Gogoi, et.,al., 
conducted a study titled “Association of Serum Calcium Levels with 
Infarct Size in Acute Ischemic Stroke: Observations from Northeast India 
” with the aim of  determining the correlation between serum calcium 
(total, corrected, and ionized) and infarct size (IS) in patients with acute 
ischemic stroke. The result of the study revealed was, the levels of total 
calcium, albumin ଡcorrected calcium, and ionized calcium was 9.61 ± 
48 
 
0.96 mg/dl (range: 7.84–11.5), 9.72 ± 0.97 mg/dl (range: 7.92–11.66), 
and 4.82 ± 0.51 mg/dl (range: 3.9–5.9). Mean IS as measured on the CT 
scan was 45.44 ± 18.2 cm3 (range: 16–94). The levels of total protein and 
albumin in the patients with ischemic stroke was 7.43 ± 0.61 g/dl (range: 
5–8.4) and 3.87 ± 0.39 g/dl (range: 2.3–4.9). Total calcium, albumin ଡ
corrected calcium, and ionized calcium had a significant negative 
correlation with IS with r = í0.578, í0.5396, and í 0.5335. Pearson’s 
correlation coefficient for serum albumin and IS was not statistically 
coefficient (r = í0.0463, P = 0.7226). Finally the author concluded the 
study stating that total, corrected, and ionized calcium had a statistically 
significant correlation with IS in ischemic stroke and from the inference 
of the study it was suggested that serum calcium can be used as a 
prognostic indicator in ischemic stroke as it directly correlates with the 
IS. 
 “Clinico-radiological correlation between serum calcium and acute 
ischemic stroke” the observational study conducted by Gaurav M 
Kasundra, IshaSood, et.,al…In this study the author stated that Higher Ca 
(Cca in some subgroups) is associated with better prognosis and recovery 
after AIS (except in posterior circulation strokes), and higher Ca and Cca 
are both associated with smaller IS. Serum Ca had a significant 
correlation with NIHSS at admission, NIHSS after 1 week, change in 
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NIHSS, BI, and IS (r-values: í0.3915, í0.4473, 0.2986, 0.5267, and 
í0.4256, respectively). , Ca had significant (P < 0.05) correlation with 
NIHSS (admission) and highly significant (P < 0.001) correlation with 
BI. Among all patients, correlation of Ca with NIHSS was stronger after 
1 week (r-value: í0.4473; P-value: 0.0011) than at admission (r-value: 
í0.3915; P-value: 0.0048).  It was also found the calcium levels to have a 
better correlation, compared to the corrected calcium level. Cca had a 
significant (P < 0.05) correlation only with BI among all patients and the 
anterior circulation stroke subgroups and none of the other stoke 
subgroups or with NIHSS in any of the groups or subgroups analysed. 
From these inferences the author concluded the study stating that Serum 
calcium level, and not albumin-corrected calcium level, has a significant 
positive correlation with early (1 week post-stroke) recovery after 
ischemic stroke. 
               Serum calcium in acute ischemic stroke: correlation with stroke 
severity and outcome, the study done by Marwa Mohammed Ghanem and 
ThaKamelAloush. It was a cross sectional study and the  main aim of the 
study was to correlate the serum calcium level on one hand and the size 
of infarction and the stroke outcome The study results showed that serum 
calcium values were found to decrease in patients with cerebral 
infarction, higher serum calcium levels both early and late were 
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associated with smaller cerebral infarct volume on DWI and that an 
inverse correlation exists between late serum calcium level and stroke 
outcome; and this puts a highlight on the role of both calcium compounds 
and calcium antagonists in ischemic brain injury. 
             Agursuryawan, AABN Nuartha, et., al. conducted a study titled 
“Low adjusted serum calcium level as a predictor of poor outcome in 
patient with acute ischemic stroke”, a prospective cohort study. The main 
aim of the study was to determine whether calcium can be used as a 
predictor of poor outcome in patients with acute ischemic stroke. NIHSS 
score was used. Chi square was used for analysis. The study revealed that 
lower adjusted serum calcium levels accompanied by poor outcome with 
RR-3.2, 95% CI = 1.34 to 7.62,p-value 0.00, multivariate analysis done 
revealed serum calcium as independent predictor of poor outcome in 
patients with acute ischemic stroke. From all these inferences, author 
concluded the study stating that low adjusted serum calcium as an 
independent predictor of poor outcome in patients with acute ischemic 
stroke.  
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 AIMS AND OBJECTIVES 
AIMS 
         To determine serum calcium as an prognostic marker in Acute 
ischemic stroke. 
OBJECTIVES  
          1. To study the role of serum calcium as a severity marker of acute 
ischemic stroke. 
2. To correlate serum calcium level with severity of stroke using 
NIHSS stroke score and assessing the prognosis. 
 
 
 
 
 
 
 
 
52 
 
METHODOLOGY 
Study design: 
  A cross sectional study  
Study duration: 
The ethical approval for the study was obtained from the 
institutional ethical committee in the month of April 2017 and the sample 
collection were collected following the ethical approval, and the study 
completed in the month of September 2017.The total study duration was 
6 months.  
Study setting: 
The study was conducted in the Government Stanley medical 
college and hospital, Chennai. The samples were selected among the 
inpatients who were admitted under the department of general medicine 
.The patients diagnosed with acute ischemic stroke were listed and among 
the listed patients the samples are selected based on the inclusion criteria. 
Study population: 
Inclusion criteria: 
1- Age group from18 to 80 years. 
2- Both sexes are included. 
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3- Acute ischemic stroke diagnosed by clinical examination and CT 
brain plain. 
4- Patients who are willing to participate in the study –consent form 
signed by patient or attender. 
Exclusion criteria: 
1- Patients with age more than 80 years were excluded. 
2- Patients with malignancy 
3- Patients with clinical findings and blood investigations suggestive 
of infection were excluded. 
4- Patients with prior history of transient ischemic attacks or 
reversible ischemic neurological deficit. 
5- Patients with features of hemorrhage confirmed by CT. 
6- History of recent surgery and trauma. 
7- Patients who did not give consent and who were not willing to 
participate in the study. 
8- Prolong drug history like steroids. 
Study setting: 
75 patients who were admitted in the ward as inpatient under the 
department of general medicine with CT confirmed ischemic stroke, in 
Government Stanley medical college and hospital, Chennai. 
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Study tool:  
      Questionnaire including the socio demographic factors and the 
standardized questionnaire for analysing the level of calcium in ischemic 
stroke. 
Study method: 
75 patients who diagnosed to be a case of ischemic stroke 
confirmed by CT /MRI were selected for study by simple random 
method. Data was collected using a standardized questionnaire either 
from the patient or the patient’s attender .General examination, clinical 
examination and neurological examination was done. The routine blood 
investigations such as complete blood count, renal function test, Liver 
function test, etc…were done for the selected patients. CT was done for 
confirmation of diagnosis. All the data inferred were recorded in the 
standard proforma.Corrected calcium was calculated using the CCa= 
Total calcium+0.8(4 - patients albumin level).The value obtained is 
correlated with NIHSS scoring.National Institute of Health Stroke Scale 
were calculated. Based on the scores, the patients are categorized as mild, 
moderate and severe. The patients were treated with standard treatment 
protocol .It was made sure that no patient involved in the study were 
thrombolysed. Only the measures to reduce the edema were undertaken 
and drugs such as Mannitol through intravenous route or oral glycerol are 
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used. Modified Rankin Scale was applied to the study patients and the 
score was calculated after 4 weeks of follow up period.                        
Department of General medicine 
 
Patients attending the Outpatient department 
 
Features suggestive of Stroke 
 
CT –Brain plain 
 
Confirmation of Ischemic stroke 
                                                              After getting consent 
                                                                 (Verbal /written ) 
Study samples (75) 
 
Check for corrected calcium 
 
                                  Result associated with NIHSS 
 
Severity assessed. 
 
MRS score measured after 4 weeks 
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Statistical analysis: 
 The data collected entered in MS-EXCEL and coding done for 
further statistical analysis .The statistical analysis done using the SPSS 
software version 21.Multivariate analysis, Pearson correlation analysis 
and chi –square test is applied for significance .p value <0.05 is 
considered as significant .The results are represented in the form of  
frequency tables, graphs and figures. 
Ethical consideration: 
  The study was conducted after obtaining the ethical approval from 
the institutional ethical committee of Government Stanley medical 
college and hospital on April 2017.The aim and objective of the study 
and purpose of the study, mentioning that the details shared will be kept 
confidential were included in the informed consent. The details are kept 
confidential. 
Operational definitions  
HYPERTENSION: 
          The risk of stroke is increased four to six times in hypertensive 
patients. Since hypertension promotes the atheroma formation in all sized 
vessels of brain, hypertension is considered as important risk factor for 
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stroke. Prolonged treatment of diastolic BP to produce a fall of 6mm Hg 
decrease the stroke risk by 40% and the benefits occur within 3 years. 
DIABETES: 
         Diabetic individuals are three times more prone for than individuals 
who are not diabetic. Diabetes also promotes the atheroma formation, 
thereby increasing the rate of occlusion of intracranial arteries. Impaired 
glucose tolerance may be a risk factor and elevated glycosylated 
haemoglobin may be found in up to 42% patients with cerebral infarcts 
not previously known to have diabetes. 
SMOKING: 
          Smoking increases the stroke risk by two times. Smoking causes 
vasoconstriction, increases fibrinogen concentration, causes 
polycythaemia, reduces aggregation of platelets, all these contributes 
stroke occurrence. There is a dose response relationship, the risk doubling 
in the heaviest of smokers17. In the Framingham study, cessation of 
smoking removed the additional risk of stroke within 2 years. 
ALCOHOL: 
        High Alcohol Consumption increases the risk of stroke. There is 
evidence for an association between sudden heavy drinking and the onset 
of cerebral infarction in young adults. Chronic light alcohol intake is 
58 
 
associated with a decreased risk of stroke. Chronic heavy consumption 
180 – 400 g/wk. is associated with an increased risk. 
NIHSS SCORE 
           NIHSS scoring was made based on the clinical parameters. In this 
study, patients with a score of 1- 4 were considered as MILD, score 5-15 
were considered as MODERATE, score >15 were considered as 
SEVERE category. 
MRS score 
           MRS score of 3,4,5,6 were included under Good Outcome and 
scores of 1, 2 were considered as Poor outcome. 
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RESULTS 
The study participants were distributed based on their calcium 
levels such as individuals with low calcium and normal calcium level. 
Out of 75 participants, 45 (60%) patients presented with ischemic stroke 
had low serum calcium while 30 (40%) participants had normal level of 
serum calcium. 
 
Chart 1: Distribution of study participants based on their calcium 
Table 5: Frequency distribution of study participants 
 
60%
40%
Study Subjects
Low Blood Calcium
Normal Blood
Calcium
Study Subjects 
 
Low Blood Calcium Normal Blood 
Calcium 
Number 45 30 
Percentage 60.00 40.00 
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AGE WISE DISTRIBUTION 
75 patients diagnosed with acute ischemic stroke were included in 
the study, of which 45 had low serum calcium and 30 participants had 
normal serum calcium.  Among the participants with low serum calcium, 
most of the patients were in the age group 61 to 70 years with 55.56% 
(25)  followed by 51-60 years of age with 24.4% (11), 13.3% (6) were in 
the age group 71 -80 years. Least number of patients was noted in the age 
group 41-50 years with 6.67% (3). No patients were under the age of 40 
years had low serum calcium. Among the patients with normal calcium 
level highest were in the age group 51-60 years with 56.57% (17) 
followed by the participants in the group 41-50 years with 16.67% (5). 
13.3% (4) belong to the age group 61- 70 years .13.3% (4) of patients less 
than 40 years of age also had normal serum calcium while there was no 
single participant in the age group 71-80 years had normal serum 
calcium. 
 
Chart 2: showing the age distribution of the participants 
0 3
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0
0
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Age Groups
Low Blood Calcium Normal Blood Calcium
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Table 6: Frequency distribution of age of the study participants 
GENDER DISTRIBUTION 
Among 45 participants with decreased serum calcium majority 
were males with 53.3% (24) and females were less comparatively with 
46.6% (21). Out of the patients with normal serum calcium majority 
83.3% (25) belong to male gender while rest 16.6% (5) belong to female 
gender. 
 
Age 
Groups 
Low Blood 
Calcium (freq) 
Percenta
ge (%) 
Normal Blood 
Calcium (freq) 
Percenta
ge (%) 
 40 
years 
0 0.00 4 13.33 
41-50 
years 
3 6.67 5 16.67 
51-60 
years 
11 24.44 17 56.67 
61-70 
years 
25 55.56 4 13.33 
71-80 
years 
6 13.33 0 0.00 
Total 45 100.00 30 100.00 
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Gender 
Status 
Low Blood 
Calcium 
% Normal Blood 
Calcium 
% 
Male 24 53.33 25 83.33 
Female 21 46.67 5 16.67 
Total 45 100.0
0 
30 100.0
0 
Table 7: Frequency distribution of the participants based on gender 
 
Chart 3: Gender distribution of the participants 
DISTRIBUTION BASED ON ADDICTIONS 
Alcoholic habit 
Of all the patients assessed, 44.4% (20) of the patients with low 
serum calcium were alcoholics while 55.6% (25) participants were non-
alcoholic. Equal distribution of alcoholic and non-alcoholic was noted in 
participants with normal level calcium with 50% (50) each.  
24
21
25
5
0
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25
30
Male Female
Gender Status
Low Blood Calcium Normal Blood Calcium
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Chart 4: Distribution based on alcoholic status 
Alcoholic 
status 
 
Low serum 
calcium 
% Normal serum 
calcium 
% 
Yes  20 44.4% 15 50% 
No  25 55.6% 15 50% 
Total  45 100% 30 100% 
Table 8: Frequency distribution based on the addiction to alcohol 
Smoking habit 
Among 45 patients in the low serum calcium category majority 
57.8% (26) were non-smokers while 42.2% (19) had the positive history 
of smoking. 73.3% (22) patients belonging to the group of normal serum 
calcium was non-smokers while 26.7% (8) was smokers. In both the 
category majority of the participants are non-smokers. 
20
25
15 15
0
5
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Yes No
Alcoholic
Low Blood Calcium Normal Blood Calcium
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Chart 5: Distribution based on the habit of smoking 
Smoking status Low serum 
calcium 
% Normal serum 
calcium 
% 
Yes  19 42.2% 8 26.7% 
No  26 57.8% 22 73.3% 
Total  45 100% 30 100% 
Table 9: Frequency distribution based on the addiction to smoking 
DISTRIBUTION BASED ON DIABETIC STATUS 
Among 45 patients who had low serum calcium most of them 
53.3% (24) was known diabetic and 46.7% (21) were non- diabetics. Out 
of 30 participants who had normal blood calcium level 26.7% (8) were 
diabetic and majority 73.3% was non diabetic. 
19
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8
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Yes No
Smoking 
Low Blood Calcium Normal Blood Calcium
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Chart 6: Distribution based on diabetic status 
Diabetes 
Mellitus 
Low Blood 
Calcium 
% Normal Blood 
Calcium 
% 
Yes 24 53.33 8 26.67 
No 21 46.67 22 73.33 
Total 45 100.00 30 100.00 
 
Table 10: Frequency based on diabetic status 
HYPERTENSION 
        Among the study participants, the 45 patients who had low serum 
calcium level had 57.8% (26) patients with positive history of 
hypertension while 42.2% (19) were normotensives.  Among the patients 
with calcium within reference range 36.7% (11) were hypertensives and 
63.3% (19) had normal blood pressure values. 
24
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Diabetes Mellitus
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Table 11: Frequency distribution based on hypertension status 
Hypertension Low Blood 
Calcium 
% Normal Blood 
Calcium 
% 
Yes 26 57.78 11 36.67 
No 19 42.22 19 63.33 
Total 45 100.00 30 100.00 
 
Chart 7: Distribution based on status of the blood pressure 
 
SPEECH DISTURBANCE 
Out of 45 patients who had their serum calcium at the low 
reference range, 95.6% (43) had disturbance in their speech while 56.7% 
(17) patients with the normal serum calcium level had the similar issue. 
To the least only 4.44% (2) patients was free from speech disturbance 
among the low calcium participants whereas 43.3% (13) of normal 
calcium persons were freed from the disturbance.  
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Table 12: Frequency distribution of participants based on speech 
disturbance 
Speech 
Disturbance 
Low Blood 
Calcium 
% Normal Blood 
Calcium 
% 
Yes 43 95.56 17 56.67 
No 2 4.44 13 43.33 
Total 45 100.0
0 
30 100.0
0 
 
Chart 8: Distribution based on the speech disturbance 
 
DISTRIBUTION BASED ON THE NIHSS SCORE 
Out of the 45 participants who presented with low levels of 
calcium majority of them (48.89%, 22) reported with severe stroke with 
NIHSS score 21-41 followed by 31.1% (14) with moderate to severe type 
of stroke NIHSS score 16-20, 17.8% (8)  had score in the range 5-15, that 
is moderate stroke and at the least 2.22% (1) had minor stroke with score 
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ranging from 1 – 4 while majority 43.3% (13) patients with normal serum 
calcium had the score 1-4 which represents minor stroke followed by 
36.7% (11) with moderate stroke of score 5-15 and 20% (6) were in the 
moderate to severe category with score 16-20. None of the participants 
with normal serum calcium had severe form of stroke. 
Table 13: Frequency distribution based on NIHSS Score 
National Institute of 
Health Stroke Scale 
Low Blood 
Calcium 
% Normal Blood 
Calcium 
% 
Minor Stroke (1-4) 1 2.22 13 43.3
3 
Moderate Stroke (5-15) 8 17.7
8 
11 36.6
7 
Moderate to severe stroke 
(16-20) 
14 31.1
1 
6 20.0
0 
Severe Stroke (21-41) 22 48.8
9 
0 0.00 
Total 45 100.
00 
30 100.
00 
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Chart 9: Distribution based on NIHSS score 
Modified Rankin scale 
Among 45 patients who had low serum calcium majority, 97.8% 
(44) had poor outcome of the disease while 80% (24) with normal 
calcium level had comparatively poor outcome. Only 2.22% (1) patient 
with low blood calcium had good prognosis whereas 20% (6) with 
normal calcium had good prognosis, which is comparatively higher. 
Table 14: Frequency distribution based on MRS 
Modified Rankin 
Scale 
Low Blood 
Calcium 
% Normal Blood 
Calcium 
% 
Good Outcome 1 2.22 6 20.00 
Poor Outcome 44 97.78 24 80.00 
Total 45 100.00 30 100.0 
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Chart 10: Distribution based on MRS 
 
When analysing the age distribution between the participants with 
the low and normal calcium level, the trend was noted in which higher 
age presentation was noted in low serum calcium group with the mean 
value 63.62 and Standard deviation 7.26 whereas in participants with 
normal calcium level the mean was 53.1% with standard deviation 8.53. 
The increased difference in mean age of the patients participated was 
statistically significant (P-value <0.05). 
Table 15: Association of Age distribution with the calcium levels 
Age Distribution Low Blood Calcium Normal Blood Calcium 
Mean 63.62 53.10 
SD 7.26 8.53 
P value  
Unpaired t Test 
<0.0001 
1
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When gender status has been analysed, it was found that the lower 
male gender presentation was observed in low calcium with 53.3% 
compared to normal serum calcium group participants with 83.3%. The 
increased difference in percentage of male patients between low calcium 
group and normal calcium group (30 percentage points, 36% lower) was 
found to be statistically significant (p <0.05).  
Table 16: Association of Gender with the calcium levels 
Gender 
Status 
Low Blood Calcium 
(%) 
Normal Blood 
Calcium (%) 
P value 
Chi Squared Test 
Male 
Female 
24(53.33) 
21(46.67) 
 
25(83.33) 
5(16.67) 
0.0071 
 
A trend of lower alcoholics presentation observed in low blood 
calcium group compared to normal blood calcium group was found to be 
statistically insignificant (p >0.05), when the alcohol intake was analysed 
with the study groups.  
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Table 17: Association of status of alcohol with the calcium levels 
Alcoholic Low Blood Calcium 
% 
Normal Blood Calcium 
% 
P value 
Chi 
Squared 
Test 
Yes 
No 
20(44.44) 
25(55.56) 
15(50.00) 
15(50.00) 
0.6373 
 
A trend of low smokers presentation observed in normal blood 
calcium group compared to low blood calcium group was found to be 
statistically insignificant (p >0.05) when statistical analysis done using 
chi squared test . 
Table 18: Association of smoking status with the calcium levels 
Smoking Low 
Blood 
Calcium 
% Normal 
Blood 
Calcium 
% P value 
Chi 
Squared 
Test 
Yes 19 42.22 8 26.67 0.1688 
No 26 57.78 22 73.33 
 
When statistically analysing diabetes mellitus status between the 
study groups, a trend of higher diabetes mellitus presentation was 
observed in low blood calcium group (53.33%) compared to normal 
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blood calcium group (26.67%). The increased difference in percentage of 
diabetes mellitus patients between low calcium group and normal calcium 
group (26.67 percentage points, 50% higher) was found to be statistically 
significant (p <0.05).  
When statistically analysing diabetes mellitus status between the 
study groups, a trend of higher diabetes mellitus presentation was 
observed in low blood calcium group (53.33%) compared to normal 
blood calcium group (26.67%). The increased difference in percentage of 
diabetes mellitus patients between low calcium group and normal calcium 
group (26.67 percentage points, 50% higher) was found to be statistically 
significant (p <0.05).  
Table 19: Association of diabetic status with the calcium levels 
Diabetes  
mellitus 
Low 
Blood 
Calcium 
% Normal 
Blood 
Calcium 
% P value 
Chi Squared 
Test 
Yes 24 53.3
3 
8 26.6
7 
0.0224 
No 21 46.6
7 
22 73.3
3 
 
On analysing hypertension status between the study groups, a trend 
of higher hypertensives  presentation observed in low blood calcium 
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group compared to normal blood calcium group was found to be 
statistically insignificant (p >0.05).  
Table 20: Association of hypertension status with the calcium levels 
Hypertension Low 
Blood 
Calcium 
% Normal 
Blood 
Calcium 
% P value Chi 
Squared 
Test 
Yes 26 57.7
8 
11 36.6
7 
0.0728 
No 19 42.2
2 
19 63.3
3 
 
When statistically analysing NIHSS score status between the study 
groups, a trend of higher NIHSS score presentation (Severe Stroke 
category (21-41)) was observed in low blood calcium group (48.89%) 
compared to normal blood calcium group (0.00%). The increased 
difference in percentage of NIHSS score (Severe Stroke category (21-
41)) presentation between low calcium group and normal calcium group 
(48.89 percentage points, 95% higher) was found to be statistically 
significant (p <0.05).  
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Table 21: Association of NIHSS with the calcium levels 
NIHSS Low  
Blood 
Calcium 
% Normal 
Blood 
Calcium 
% P value 
Chi 
Squared 
Test 
Minor Stroke (1-4) 1 2.22 13 43.33  
 
 
 
<0.0001 
Moderate Stroke 
(5-15) 
8 17.78 11 36.67 
Moderate to severe 
stroke (16-20) 
14 31.11 6 20.00 
Severe Stroke (21-
41) 
22 48.89 0 0.00 
 
When analysing Modified Rankin score status between the study 
groups, a trend of higher poor outcome status was observed in low blood 
calcium group (97.78%) compared to normal blood calcium group 
(80.00%). The increased difference in percentage of poor outcome status 
as per MRS between low calcium group and normal calcium group (17.78 
percentage points, 18% higher) was found to be statistically significant (p 
<0.05).  
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Table 22: Association of MRS with the calcium levels 
Modified 
Rankin Scale 
Low 
Blood 
Calcium 
% Normal 
Blood 
Calcium 
% P value 
Chi-Squared 
Test 
Good 
Outcome 
1 2.22 6 20.0
0 
 
 
0.0102 Poor 
Outcome 
44 97.7
8 
24 80.0
0 
 
Calcium vs NIHSS 
While evaluating the relationship between blood calcium levels 
and NIHSS scores, a positive correlation was observed with a Pearson’s 
coefficient of 0.32. It was statistically significant with a p-value of 0.0058 
according to ANOVA test. 
Chart 11: Calcium vs NIHSS
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Table 23: Correlation analysis –calcium vs NIHSS 
Correlation Analysis - Calcium Vs NIHSS 
Pearson’s R 0.3151 
R Square 0.0993 
P value 
ANOVA 
0.0058 
 
In our study blood calcium levels almost matched NIHSS scores 
steadily in a linear fashion.  The rate of increase predicted was 2.79 
NIHSS score points for every 1 gm/dl increase in blood calcium levels. 
Calcium vs MRS 
While evaluating the relationship between blood calcium levels 
and MRS scores, a positive correlation was observed with a Pearson’s 
coefficient of 0.38. It was statistically significant with a p-value of 0.0008 
according to ANOVA test. 
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Chart 12: Calcium vs MRS 
 
 
 
Table 24: Correlation analysis –calcium vs MRS 
In our study blood calcium levels almost matched MRS scores 
steadily in a linear fashion.  The rate of increase predicted was 0.49 MRS 
score points for every 1 gm /dl increase in blood calcium levels. 
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Pearson’s R 0.3781 
R Square 0.1429 
P value 
ANOVA 
0.0008 
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SUMMARY 
           Majority of the study subjects in low blood calcium group were 
distributed in 61-70 years age group (n=25, 55.56%) and 51-60 years age 
group in normal blood calcium group (n=17, 56.66%) (p= <0.0001, 
unpaired t test). The trend of higher age presentation was observed in low 
blood calcium group (63.62) compared to normal blood calcium group 
(53.10). The increased difference in mean age of patients between low 
calcium group and normal calcium group (10.52 mean years, 17% higher) 
was found to be statistically significant (p <0.05).  
Most of the study subjects in low blood calcium group most of them were 
males (n=24, 53.33%) and same in normal blood calcium group (n=25, 
83.33%)( p= 0.0071, chi squared test), a trend of lower male gender 
presentation was observed in low blood calcium group (53.33%) 
compared to normal blood calcium group (83.33%). The increased 
difference in percentage of male patients between low calcium group and 
normal calcium group (30 percentage points, 36% lower) was found to be 
statistically significant (p <0.05).  
Majority of the study subjects in low blood calcium group were non 
alcoholics (n=25, 55.56%) and equal distribution in normal blood calcium 
group (n=15, 50.00%)( p= 0.6373, chi squared test). When alcohol intake 
status between the study groups analysed, a trend of lower alcoholics 
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presentation observed in low blood calcium group compared to normal 
blood calcium group was found to be statistically insignificant (p >0.05). 
Majority of the study subjects in low blood calcium group were non-
smokers (n=26, 57.78%) and same in normal blood calcium group (n=22, 
73.33%)( p= 0.1688, chi squared test). When statistically analysing 
smoking status between the study groups, a trend of higher smokers  
presentation observed in low blood calcium group compared to normal 
blood calcium group was found to be statistically insignificant (p >0.05). 
Majority of the study subjects in low blood calcium group had diabetes 
mellitus (n=24, 53.33%) and non-diabetics in normal blood calcium 
group (n=22, 73.33%)( p= 0.0224, chi squared test). When statistically 
analysing diabetes mellitus status between the study groups, a trend of 
higher diabetes mellitus presentation was observed in low blood calcium 
group (53.33%) compared to normal blood calcium group (26.67%). The 
increased difference in percentage of diabetes mellitus patients between 
low calcium group and normal calcium group (26.67 percentage points, 
50% higher) was found to be statistically significant (p <0.05). Among  
the study subjects in low blood calcium group were hypertensives (n=26, 
57.78%) and normotensives in normal blood calcium group (n=19, 
63.33%) ( p= 0.0728, chi squared test), When analysing hypertension 
status between the study groups, a trend of higher hypertensives  
presentation observed in low blood calcium group compared to normal 
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blood calcium group was found to be statistically insignificant (p >0.05). 
Majority of the study subjects in low blood calcium group had speech 
disturbance (n=43, 95.56%) and same in normal blood calcium group 
(n=17, 56.67%) (p= <0.0001, chi squared test). When statistically 
analysing speech disturbance status between the study groups, a trend of 
higher speech disturbance presentation was observed in low blood 
calcium group (95.56%) compared to normal blood calcium group 
(56.67%). The increased difference in percentage of speech disturbance 
presentation between low calcium group and normal calcium group 
(38.89 percentage points, 41% higher) was found to be statistically 
significant (p <0.05). Majority of the study subjects in low blood calcium 
group had NIHSS score between 21-41 (n=22, 48.89%) and NIHSS score 
between 1-4 in normal blood calcium group (n=13, 43.33%) (p= <0.0001, 
chi squared test). When statistically analysing NIHSS score status 
between the study groups, a trend of higher NIHSS score presentation 
(Severe Stroke category (21-41)) was observed in low blood calcium 
group (48.89%) compared to normal blood calcium group (0.00%). The 
increased difference in percentage of NIHSS score (Severe Stroke 
category (21-41)) presentation between low calcium group and normal 
calcium group (48.89 percentage points, 95% higher) was found to be 
statistically significant (p <0.05). Majority of the study subjects in low 
blood calcium group had poor outcome as per MRS (n=44, 97.78%) and 
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same in normal blood calcium group (n=24, 80.00%) (p= 0.0102, chi 
squared test). When statistically analysing modified Rankin score status 
between the study groups, a trend of higher poor outcome status was 
observed in low blood calcium group (97.78%) compared to normal 
blood calcium group (80.00%). The increased difference in percentage of 
poor outcome status as per MRS between low calcium group and normal 
calcium group (17.78 percentage points, 18% higher) was found to be 
statistically significant (p <0.05).  
 
 
 
 
 
 
 
 
 
 
84 
 
DISCUSSION 
In our study, majority of the participants (60%) had low levels of 
serum calcium than participants with normal calcium range. The normal 
corrected calcium value taken , range from 8.6to 10.2, where  the level 
less than 8.6 is considered to be low and more than 10.2 is considered as 
high calcium level. With this corrected calcium range as base the 
distribution of participants were done.  Each group has been compared 
with the demographic factors such as age and gender along with the 
personal habits such as alcohol and smoking and also with the diabetic 
and hypertension status of the participants. Finally the calcium levels are 
compared with the NIHSS and the MRS. From all these it is found that 
majority of the study population were in the age group 61 to 70 years 
with 55.56% and the male gender was high among the study participants 
with 53.2%.  Most of the participants with low calcium level were non-
alcoholic whereas equal distribution was found among the patients with 
normal calcium values. Regarding smoking habit more number of study 
subjects belongs to low calcium group were non-smokers. 53.3% were 
diabetic among the low calcium group and 26.75% had positive history of 
diabetes mellitus among the normal serum calcium group. Most of the 
participants in the group of decreased calcium were found to be 
hypertensive compared to the participants in the category of normal blood 
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calcium. Significant association was noted between the age distribution 
and the level of calcium with p-value <0.001, gender with p-value 0.007, 
diabetes mellitus with p-value 0.022. No significant association between 
smoking, alcohol and the status of the blood pressure. Significant 
association was seen when NIHSS is compared with the calcium and the 
significance also noted when calcium is compared with MRS, with p-
value <0.0001 and 0.0102 respectively. ANOVA test was done which 
also elicited significant association between the calcium and NIHSS.  
Similar to our study, the study conducted by Guven H, Cililier AE, 
et., al.. in their study titled “Association of serum calcium levels with 
clinical severity of acute ischemic stroke” inferred that NIHSS scores 
were higher in the patients with decreased calcium levels with p-value 
<0.05. 
Similarly, the study conducted by Meghna Borah, Sriparna DhƗr, 
et.,al titled “Association of serum calcium levels with infarct size in acute 
ischemic stroke :observation from Northeast India”, concluded that 
calcium can be used as a prognostic indicator in ischemic stroke based on 
its significant association between calcium level and the size of the 
ischemic stroke. 
Similar finding also noted in the study titled “low adjusted serum 
calcium level as a predictor of poor outcome in patients with acute 
86 
 
ischemic stroke” inferred that calcium level is an important predicator of 
outcome of stroke based on the statistically significant association 
between the variable with p –value <0.001. 
In the study conducted by Abha Gupta, Umesh Dubay, et,.al.. titles 
“Correlation of serum calcium levels with severity and functional 
outcome in acute ischemic stroke patients “ stated that patients with high 
calcium had significantly less severity of the stroke and during follow up 
after 7 days the prognosis is better in patients with high calcium 
compared to the lower levels of calcium, which was statistically 
significant(p-value 0.01). 
Muhammed Ishfaq, Fahim Ullah, e,.al.. Conducted a study titled 
“correlation of serum calcium with severity of acute ischemic stroke” 
inferred that lower serum calcium is associated with more sever clinical 
finding at the onset of stroke and proved the significance with the help of 
Bivariate analysis and Pearson’s correlation coefficient was significant 
(p-value 0.005).  
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CONCLUSION 
Age of the study subjects is normally distributed across the 
intervention groups and has an effect on prognosis in patients with acute 
ischemic stroke.  Low blood calcium levels occurred in patients with age 
> 60 years consistently compared to patients with age < 60 years among 
ischemic stroke patients. Gender of the study subjects is normally 
distributed across the intervention groups has an effect on prognosis in 
patients with acute ischemic stroke.  Low blood calcium levels occurred 
in female patients consistently compared to male patients among 
ischemic stroke patients. Alcohol intake status of the study subjects is 
normally distributed across the intervention groups has no effect on 
prognosis in patients with acute ischemic stroke.  Smoking status of the 
study subjects is normally distributed across the intervention groups has 
no effect on prognosis in patients with acute ischemic stroke.  Diabetes 
mellitus presentation among study subjects is normally distributed across 
the intervention groups has an effect on prognosis in patients with acute 
ischemic stroke.  Low blood calcium levels occurred in diabetes mellitus 
patients consistently compared to non-diabetes mellitus patients among 
ischemic stroke patients.  Hypertension status of the study subjects is 
normally distributed across the intervention groups has no effect on 
prognosis in patients with acute ischemic stroke.  NIHSS score 
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presentation among study subjects is normally distributed across the 
intervention groups has an effect on prognosis in patients with acute 
ischemic stroke.  Low blood calcium levels occurred in patients with 
NIHSS score (Severe Stroke category (21-41)) consistently compared to 
patients with NIHSS score (Minor Stroke category (1-4)) among ischemic 
stroke patients. Modified Rankin score presentation among study subjects 
is normally distributed across the intervention groups has an effect on 
prognosis in patients with acute ischemic stroke.  Low blood calcium 
levels occurred in patients with poor outcome status as per MRS 
consistently compared to patients with good outcome status as per MRS 
among ischemic stroke patients. We conclude that blood calcium 
measurement can be an important additional parameter for predicting 
poor prognosis and recovery in ischemic stroke patients. 
From all these, We can conclude that: 
Alcohol intake, smoking, hypertension, hemiplegia side and facial 
nerve involvement had no statistically significant role to play on blood 
calcium levels in ischaemic stroke patients. Ischemic stroke patients with 
low blood calcium levels had bad prognosis. Female Ischemic stroke 
patients aged >60 years with low blood calcium levels and comorbid 
conditions like diabetes mellitus had grave prognosis. 
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LIMITATIONS: 
Our study has a major limitation of small sample size, and no data 
was collected on ionized calcium which is a physiological active 
component of calcium. In addition to this limitation, the serum calcium is 
measured during admission irrespective of stroke onset time interval. 
Patients with unrecognized malignancy and with hypo parathyroid 
disorders also have a low calcium level which leads to misconception of 
the outcome. 
RECOMMENDATIONS: 
Serum calcium levels may reflect the severity of ischemic injury. 
Further trials will be required to clarify the mechanism of this effect and 
to assess the role of serum calcium level as a prognostic variable and of 
calcium modulation as part of a strategy for prevention of stroke. We also 
suggest further research on the relationship between adjusted serum 
calcium levels with the outcome of acute ischemic stroke patients with 
consideration for the aforementioned weaknesses. 
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